Literature DB >> 22105366

NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells.

S Yoon1, S U Woo, J H Kang, K Kim, H-J Shin, H-S Gwak, S Park, Y-J Chwae.   

Abstract

A number of genes involved in tumorigenesis have been known to be controlled by signal transducer and activator of transcription 3 (STAT3) and NF-κB, either synergistically or individually. In starved cancer cells, we found that NF-κB was activated through endoplasmic reticulum stress signals, which depend on reactive oxygen species, cytosolic calcium and preserved translation of NF-κB p65 subunit, but independent of IκBα serine phosphorylation, thereby resulting in IL6 induction. STAT3 was required for proper induction of IL6 by NF-κB. They existed as identical nuclear complexes in proximal IL6 promoters, and STAT3 had critical roles in binding to IL6 promoters as well as nuclear retention of NF-κB. The conditioned media from starved cancer cells contained various secretory factors, such as IL6, IL9, VWF (von Willebrand factor), FREM1 (FRAS1 related extracellular matrix 1), SAA1 (serum amyloid A1), SDK1 (sidekick homolog 1) and ADAM12 (ADAM metallopeptidase domain 12), induced by NF-κB and STAT3 and promoted clonogenic capacities of cancer cells, and proliferation and migration of human umbilical vein endothelial cells. These results suggest novel survival strategies of cancer cells by which two oncogenic transcriptional factors, NF-κB and STAT3, are activated simultaneously by an intrinsic mechanism during stressful conditions of cancer cells, and they cooperatively induce various survival factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105366     DOI: 10.1038/onc.2011.517

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

Review 1.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

2.  A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

Authors:  Haihui Lu; Karl R Clauser; Wai Leong Tam; Julia Fröse; Xin Ye; Elinor Ng Eaton; Ferenc Reinhardt; Vera S Donnenberg; Rohit Bhargava; Steven A Carr; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-09-28       Impact factor: 28.824

3.  FRAS1 knockdown reduces A549 cells migration and invasion through downregulation of FAK signaling.

Authors:  Qiong Zhan; Ruo-Fan Huang; Xiao-Hua Liang; Meng-Xi Ge; Jing-Wei Jiang; Hao Lin; Xin-Li Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

4.  Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.

Authors:  Satu Mäki-Nevala; Virinder Kaur Sarhadi; Aija Knuuttila; Ilari Scheinin; Pekka Ellonen; Sonja Lagström; Mikko Rönty; Eeva Kettunen; Kirsti Husgafvel-Pursiainen; Henrik Wolff; Sakari Knuutila
Journal:  Lung       Date:  2016-02       Impact factor: 2.584

5.  PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation.

Authors:  Gordon P Meares; Yudong Liu; Rajani Rajbhandari; Hongwei Qin; Susan E Nozell; James A Mobley; John A Corbett; Etty N Benveniste
Journal:  Mol Cell Biol       Date:  2014-08-11       Impact factor: 4.272

Review 6.  Inflammatory signaling cascades and autophagy in cancer.

Authors:  Teresa Monkkonen; Jayanta Debnath
Journal:  Autophagy       Date:  2017-09-18       Impact factor: 16.016

7.  Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.

Authors:  Jun-Xia Zhang; Jing Zhang; Wei Yan; Ying-Yi Wang; Lei Han; Xiao Yue; Ning Liu; Yong-Ping You; Tao Jiang; Pei-Yu Pu; Chun-Sheng Kang
Journal:  Neuro Oncol       Date:  2013-01-07       Impact factor: 12.300

8.  Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.

Authors:  Belen Elguero; Geraldine Gueron; Jimena Giudice; Martin A Toscani; Paola De Luca; Florencia Zalazar; Federico Coluccio-Leskow; Roberto Meiss; Nora Navone; Adriana De Siervi; Elba Vazquez
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

9.  p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Authors:  Bangxing Hong; Haiyan Li; Mingjun Zhang; Jingda Xu; Yong Lu; Yuhuan Zheng; Jianfei Qian; Jeffrey T Chang; Jing Yang; Qing Yi
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

10.  Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer.

Authors:  Seung Won Kim; Ki Cheong Park; Soung Min Jeon; Tak Bum Ohn; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Cell Oncol (Dordr)       Date:  2013-02-02       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.